News und Aktuelles

Aktuelle Pressemeldungen, Vorträge und Veranstaltungen


New Publication: Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer

Cologne, 02 July 2020 – The paper, published in the journal Cancers, evaluates and discusses the clinical utility of Tumor mutation burden (TMB) in a 417 patient Non-Small Cell Lung Cancer (NSCLC) cohort. It provides an example of how highly complex biomarkers such as TMB can be implemented into routine laboratory diagnostics using the NEOplus v2 RUO assay.

Read full article